Addex Therapeutics Ltd. (ADXN) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

CHF 30.0K

Net Income/Loss (FY2025)

-CHF 6.7M

Total Assets (FY2025)

CHF 6.4M

Total Equity (FY2025)

CHF 4.8M

Cash Flows from Operating Activities (FY2025)

-CHF 2.2M

Source: Addex Therapeutics Ltd. 20-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.